Outcomes of Stages I and II Follicular Lymphoma in the Era of 18F-FDG PET-CT Staging: An International Collaborative Study from the Australian Lymphoma Alliance

被引：0

作者：

Tobin, Joshua W. D. ^{[1
,2
]}

Rule, Gabrielle ^{[3
]}

Colvin, Katherine ^{[4
]}

Calvente, Lourdes ^{[5
]}

Hodgson, David C. ^{[6
]}

Dunduru, Chengetai ^{[7
]}

Bell, Stephen ^{[8
]}

Gallo, James ^{[9
]}

Tsang, Erica ^{[10
]}

Tan, Xuan ^{[11
]}

Pearce, Jessica ^{[12
]}

Wong, Jonathan ^{[13
]}

Campbell, Robert ^{[14
]}

Tneh, Shao Yang ^{[15
]}

Shorten, Sophie ^{[16
]}

Ng, Melissa Liet Hing ^{[17
]}

Darch, Jacob ^{[18
]}

Cochrane, Tara ^{[17
]}

Tam, Constantine S. ^{[19
,20
]}

Abro, Emad Uddin ^{[21
]}

Hawkes, Eliza ^{[22
,23
]}

Hodges, Georgina ^{[12
]}

Talaulikar, Dipti ^{[24
]}

Gilbertson, Michael P. ^{[13
]}

Johnson, Anna ^{[25
]}

Kansara, Roopesh R. ^{[26
]}

Villa, Diego ^{[27
]}

Savage, Kerry J. ^{[28
]}

Morris, Kirk Lachlan ^{[29
]}

Janowski, Wojt ^{[30
]}

Ratnasingam, Sumita ^{[7
]}

Kridel, Robert ^{[31
]}

Cheah, Chan Y. ^{[32
]}

Gandhi, Maher K. ^{[2
]}

Hapgood, Greg ^{[33
]}

机构：

[1] Univ Queensland, Diamantina Inst, Blood Canc Res Lab, Brisbane, Qld, Australia

[2] Princess Alexandra Hosp, Dept Haematol, Brisbane, Qld, Australia

[3] Sir Charles Gairdner Hosp, Dept Haematol, Perth, WA, Australia

[4] Sir Charles Gairdner Hosp, Dept Haematol, Nedlands, WA, Australia

[5] Princess Margaret Canc Ctr, Dept Med Oncol & Hematol, Toronto, ON, Canada

[6] Princess Margaret Hosp, Toronto, ON, Canada

[7] Geelong Univ Hosp, Dept Haematol, Geelong, Vic, Australia

[8] Calvary Mater Hlth, Dept Haematol, Newcastle, NSW, Australia

[9] Royal Brisbane Hosp, Dept Haematol, Brisbane, Qld, Australia

[10] BC Canc, Div Med Oncol, Vancouver, BC, Canada

[11] Royal Hobart Hosp, Dept Haematol, Hobart, Tas, Australia

[12] Townsville Hosp, Townsville, Qld, Australia

[13] Monash Hlth, Dept Haematol, Clayton, Vic, Australia

[14] Austin Hlth, Olivia Newton John Canc Res & Wellness Ctr, Dept Med Oncol & Clin Hematol, Heidelberg, Vic, Australia

[15] Mater Hosp Brisbane, Dept Haematol, Brisbane, Qld, Australia

[16] St Vincents Hlth Australia, Dept Hematol, Fitzroy, Vic, Australia

[17] Gold Coast Univ Hosp, Dept Hematol, Southport, Qld, Australia

[18] Gold Coast Univ Hosp, Dept Hematol, Gold Coast, Australia

[19] St Vincents Hosp, Dept Hematol, Fitzroy, Vic, Australia

[20] Univ Melbourne, Melbourne, Vic, Australia

[21] Mater Hosp Brisbane, Brisbane, Qld, Australia

[22] Austin Hosp, Melbourne, Vic, Australia

[23] Olivia Newton John Canc Res Inst, Melbourne, Vic, Australia

[24] Canberra Hosp, Haematol Dept, Haematol Translat Res Unit, Red Hill, Australia

[25] Royal Hobart Hosp, Dept Haematol, Hobart, Tas, Australia

[26] Canc Care Manitoba, Winnipeg, MB, Canada

[27] BC Canc Agcy, Ctr Lymphoid Canc, Vancouver, BC, Canada

[28] British Columbia Canc Ctr, Vancouver, BC, Canada

[29] Royal Brisbane & Womens Hosp, Herston, Qld, Australia

[30] Calvary Mater Newcastle, Waratah, Waratah, Australia

[31] Univ Toronto, Princess Margaret Canc Ctr, Div Med Oncol & Hematol, Toronto, ON, Canada

[32] Sir Charles Gairdner Hosp, Nedlands, WA, Australia

[33] Princess Alexandra Hosp, Canc Care Serv, Brisbane, Qld, Australia

来源：

BLOOD | 2018年 / 132卷

关键词：

D O I：

10.1182/blood-2018-99-114097

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

4148

引用

页数：4

共 50 条

[31] The role of 18F-FDG PET/CT radiomics in lymphoma
Rizzo, Alessio
Triumbari, Elizabeth Katherine Anna
Gatta, Roberto
Boldrini, Luca
Racca, Manuela
Mayerhoefer, Marius
Annunziata, Salvatore
CLINICAL AND TRANSLATIONAL IMAGING, 2021, 9 (06) : 589 - 598
[32] The role of 18F-FDG PET/CT in patients with lymphoma
Munoz Iglesias, J.
Iglesias, R.
Groiss, J.
Infante, J.
Rayo, I.
Dominguez, M.
Garcia, L.
Duran, C.
Serrano, J.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 : S336 - S336
[33] 18F-FDG PET/CT role in Burkitt lymphoma
Albano, Domenico
Bertagna, Francesco
Giubbini, Raffaele
CLINICAL AND TRANSLATIONAL IMAGING, 2020, 8 (01) : 39 - 45
[34] 18F-FDG PET/CT impact in grade 3B follicular lymphoma
Albano, Domenico
BRITISH JOURNAL OF HAEMATOLOGY, 2024, 205 (06) : 2134 - 2135
[35] Prediction of prognosis and pathologic grade in follicular lymphoma using 18F-FDG PET/CT
Li, Hongyan
Wang, Min
Zhang, Yajing
Hu, Fan
Wang, Kun
Wang, Chenyang
Gao, Zairong
FRONTIERS IN ONCOLOGY, 2022, 12
[36] Role of 18F-FDG PET / CT in treatment decision making in patients with follicular lymphoma
Li, Hebei
Wang, Qian
Zhao, Yunyun
JOURNAL OF NUCLEAR MEDICINE, 2018, 59
[37] Prognostic value of metabolic criteria with 18F-FDG PET / CT in patients with follicular lymphoma
Cozar Santiago, M.
Garcia Garzon, J.
Soler Peter, M.
Igua Saenz, C.
Sanz Llorens, R.
Sanchez-Jurado, R.
Aguilar Barrios, J.
Faus Rodrigo, V.
Riera Gil, E.
Ferrer Rebolleda, J.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S724 - S725
[38] Axillary schwannoma mimicking lymphadenopathy in a patient with follicular lymphoma on 18F-FDG PET/CT
Cui, Y.
Li, X.
Li, Y.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S852 - S852
[39] Utilization of 18F-FDG PET/CT as a staging tool in patients with newly diagnosed lymphoma
Cho, Shih-Feng
Chang, Chin-Chuan
Liu, Yi-Chang
Chang, Chao-Sung
Hsiao, Hui-Hua
Liu, Ta-Chih
Huang, Chiung-Tang
Lin, Sheng-Fung
KAOHSIUNG JOURNAL OF MEDICAL SCIENCES, 2015, 31 (03): : 130 - 137
[40] The value of the novel quantitative method for PET/CT in staging 18F-FDG avid lymphoma
He, W.
Zhai, W.
Elsner, A.
Bertling, S.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 : S507 - S507

← 1 2 3 4 5 →